COVID-19 Vaccines and Epidemiology Division, Public Health Programmes Directorate UK Health Security Agency London UK.
Genomics Public Health Analysis, TARZET Division, Clinical and Emerging Infections Directorate UK Health Security Agency London UK.
Influenza Other Respir Viruses. 2023 Nov;17(11):e13204. doi: 10.1111/irv.13204.
The emergence of the SARS-CoV-2 Beta (B.1.351) variant in November 2020 raised concerns of increased transmissibility and severity. We describe the epidemiology of 949 confirmed SARS-CoV-2 Beta variant cases in England, identified between December 2020 and June 2022. Most cases were detected in the first 3 months. A total of 10 deaths (1.1%; 10/949) were identified among all cases and of those with travel information, 38 (4.9%; 38/781) cases with hospital admissions within 14 days of a positive test being detected. 52.9% (413/781) cases were imported. This study reinforces the importance of monitoring of travel-associated cases to inform public health response and reduce transmissibility of new variants.
2020 年 11 月，SARS-CoV-2 Beta（B.1.351）变异株的出现引起了人们对其传染性和严重性增加的担忧。我们描述了 2020 年 12 月至 2022 年 6 月期间在英国发现的 949 例确诊的 SARS-CoV-2 Beta 变异株病例的流行病学情况。大多数病例是在前 3 个月发现的。在所有病例中，共发现 10 例死亡（1.1%；10/949），在有旅行信息的病例中，在检测呈阳性后 14 天内住院的 38 例（4.9%；38/781）。52.9%（413/781）的病例为输入性病例。本研究强调了监测与旅行相关病例的重要性，以便为公共卫生应对措施提供信息，并降低新变异株的传播性。
